Below are the most recent publications written about "Health Expenditures" by people in Profiles.
-
Sadigh G, Duan F, An N, Gareen ID, Sicks J, Suga JM, Kehn H, Mehan PT, Bajaj R, Hanson DS, Dalia SM, Acoba JD, Yasar DG, Taylor MA, Park E, Wagner LI, Kircher SM, Carlos RC. Financial Hardship Among Patients With Early-Stage Colorectal Cancer. JAMA Netw Open. 2024 Sep 03; 7(9):e2431967.
-
Zheng J, Abudayyeh I, Rakovski C, Ehwerhemuepha L, Mianroodi AR, Patel JN, Ihab A, Ani C. Trends in heart failure costs for commercially insured patients in the United States (2006-2021). BMC Health Serv Res. 2024 Jul 08; 24(1):780.
-
Arbanas JC, Damberg CL, Leng M, Harawa N, Sarkisian CA, Landon BE, Mafi JN. Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program. JAMA Intern Med. 2023 08 01; 183(8):885-889.
-
Enyeji AM, Barengo NC, Ibrahimou B, Ramirez G, Arrieta A. Association between Non-Dietary Cardiovascular Health and Expenditures Related to Acute Coronary Syndrome in the US between 2008-2018. Int J Environ Res Public Health. 2023 05 08; 20(9).
-
Morrar R, Jabr S, Ghandour R, Abu-Rmeileh NM, Forgione DA, Younis M. Identifying healthcare cost drivers in Palestine. Int J Health Plann Manage. 2021 May; 36(3):911-924.
-
Broder-Fingert S, Lindly O, Zuckerman KE. Variability in Expenditures for Autism: A Canary in the Coal Mine for Disparities in Care? Psychiatr Serv. 2021 01 01; 72(1):98-99.
-
DeJong C, Masuda C, Chen R, Kazi DS, Dudley RA, Tseng CW. Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D. JAMA Intern Med. 2020 12 01; 180(12):1696-1699.
-
Esquivel MK, Higa A, Hitchens M, Shelton C, Okihiro M. Keiki Produce Prescription (KPRx) Program Feasibility Study to Reduce Food Insecurity and Obesity Risk. Hawaii J Health Soc Welf. 2020 05 01; 79(5 Suppl 1):44-49.
-
Chima CC, Bruce MA, Pendergrass DB, Thorpe RJ, Ward LM, Blackburn HF, Palombo CF, Beech BM. Strengthening the U. S. Medication Safety Net by Connecting Abundance to Need. J Health Care Poor Underserved. 2020; 31(2):503-518.
-
Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H, Shahinian V. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019 03; 73(3 Suppl 1):A7-A8.